Latest Blood disorders Stories
According to a recent study, two related enzymes, phosphoinositide-3 kinase (PI3k) gamma and delta, have been found to have a role in the development of an aggressive childhood leukemia (T-cell acute lymphoblastic leukemia (T-ALL)) that is highly difficult to treat.
Columbia University Medical Center (CUMC) scientists have demonstrated that two related enzymes — phosphoinositide-3 kinase (PI3K) gamma and delta — play a key role in the development of T-cell acute lymphoblastic leukemia (T-ALL), a highly aggressive childhood leukemia that is difficult to treat.
Through a groundbreaking new gene sequencing technology, researchers have demonstrated that the gene FLT3 is a valid therapeutic target in Acute Myeloid Leukemia, AML, one of the most common types of leukemia.
The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research led by physician-scientists at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
- a meat pie that is usually eaten at Christmas in Quebec
More Images (1 images) »